Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples.

Journal of clinical pathology - 18 Jul 2024

Guillard Matthieu, Caumont Charline, Marcorelles Pascale, Merlio Jean-Philippe, Cappellen David, Uguen Arnaud

Abstract excerpt

AIMS: We aimed to evaluate the performances of the Idylla GeneFusion Assay (IGFA) designed to detect, in a single, rapid and fully automated assay, ALK, ROS1, RET, NTRK1, NTRK2 and NTRK3 gene fusions and MET exon 14 skipping in cancer samples. METHODS: Based on a set of tumours enriched in cases with gene fusions, we applied the IGFA to tumour areas of various sizes and tumour cell contents. IGFA results were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Gene Fusion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Immunohistochemistry

Share to In Situ Hybridization, Fluorescence

Share to Oncogene Proteins, Fusion

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 37185257
DOI: 10.1136/jcp-2023-208798

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performances of the Idylla GeneFusion Assay: contribution to a rapid diagnosis of targetable gene fusions in tumour samples.PMID 37185257Read ↗

Multicenter Evaluation of the Idylla GeneFusion in Non-Small-Cell Lung Cancer.Semantic proximity Read ↗

Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers.Semantic proximity Read ↗

Multicenter evaluation of an automated, multiplex, RNA-based molecular assay for detection of ALK, ROS1, RET fusions and MET exon 14 skipping in NSCLCSemantic proximity Read ↗

Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study.Semantic proximity Read ↗

NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategiesSemantic proximity Read ↗

Ultrasensitive gene fusion detection reveals fusion variant associated tumor heterogeneitySemantic proximity Read ↗

Expert consensus on the diagnosis and treatment of NTRK gene fusion solid tumors in ChinaSemantic proximity Read ↗

Genomic context of NTRK1/2/3 fusion-positive tumours from a large real-world populationSemantic proximity Read ↗

Multidisciplinary consensus on optimising the detection of NTRK gene alterations in tumoursSemantic proximity Read ↗

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLCSemantic proximity Read ↗

[Diagnosis and therapy of tumors with NTRK gene fusion].Semantic proximity Read ↗

Testing NTRK testing: Wet‐lab and in silico comparison of RNA‐based targeted sequencing assaysSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.